| Issue Date | Title | Author(s) |
| 2008-10-01 | A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies | Stelzer-Braid, S; Wong, B; Robertson, P; Lynch, GW; Laurie, K; Shaw, R; Barr, I; Selleck, PW; Baleriola, C; Escott, R; Katsoulotos, G; Rawlinson, WD |
| 2015-11 | Avian influenza in Australia: a summary of 5 years of wild bird surveillance. | Grillo, VL; Arzey, KE; Hansbro, PM; Hurt, AC; Warner, S; Bergfeld, J; Burgess, GW; Cookson, B; Dickason, CJ; Ferenczi, M; Hollingsworth, T; Hoque, M; Jackson, RB; Klaassen, M; Kirkland, PD; Kung, NY; Lisovski, S; O'Dea, MA; O'Riley, K; Roshier, D; Skerratt, LF; Tracey, JP; Wang, X; Woods, R; Post, L |
| 2022-11-15 | Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice. | Ashhurst, AS; Johansen, MD; Maxwell, JWC; Stockdale, S; Ashley, CL; Aggarwal, A; Siddiquee, R; Miemczyk, S; Nguyen, DH; Mackay, JP; Counoupas, C; Byrne, SN; Turville, S; Steain, M; Triccas, JA; Hansbro, PM; Payne, RJ; Britton, WJ |
| 2022 | Opinion: The use of chicken IgY in the control of pandemics. | Wallach, MG |
| 2021-12-14 | Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability. | Burnett, DL; Jackson, KJL; Langley, DB; Aggrawal, A; Stella, AO; Johansen, MD; Balachandran, H; Lenthall, H; Rouet, R; Walker, G; Saunders, BM; Singh, M; Li, H; Henry, JY; Jackson, J; Stewart, AG; Witthauer, F; Spence, MA; Hansbro, NG; Jackson, C; Schofield, P; Milthorpe, C; Martinello, M; Schulz, SR; Roth, E; Kelleher, A; Emery, S; Britton, WJ; Rawlinson, WD; Karl, R; Schäfer, S; Winkler, TH; Brink, R; Bull, RA; Hansbro, PM; Jäck, H-M; Turville, S; Christ, D; Goodnow, CC |
| 2022-01 | Clinical features and mechanistic insights into drug repurposing for combating COVID-19. | Asrani, P; Tiwari, K; Eapen, MS; McAlinden, KD; Haug, G; Johansen, MD; Hansbro, PM; Flanagan, KL; Hassan, MI; Sohal, SS |
| 2021-02-04 | SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays | Walker, GJ; Naing, Z; Stella, AO; Yeang, M; Caguicla, J; Ramachandran, V; Isaacs, SR; Agapiou, D; Bull, RA; Stelzer-Braid, S; Daly, J; Gosbell, IB; Hoad, VC; Irving, DO; Pink, JM; Turville, S; Kelleher, AD; Rawlinson, WD |
| 2022-11 | Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection. | Wang, Y; Wang, X; Luu, LDW; Li, J; Cui, X; Yao, H; Chen, S; Fu, J; Wang, L; Wang, C; Yuan, R; Cai, Q; Huang, X; Huang, J; Li, Z; Li, S; Zhu, X; Tai, J |
| 2023-02-08 | Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients. | Rouet, R; Henry, JY; Johansen, MD; Sobti, M; Balachandran, H; Langley, DB; Walker, GJ; Lenthall, H; Jackson, J; Ubiparipovic, S; Mazigi, O; Schofield, P; Burnett, DL; Brown, SHJ; Martinello, M; Hudson, B; Gilroy, N; Post, JJ; Kelleher, A; Jäck, H-M; Goodnow, CC; Turville, SG; Rawlinson, WD; Bull, RA; Stewart, AG; Hansbro, PM; Christ, D |
| 2014-01-01 | Influenza A HA's conserved epitopes and broadly neutralizing antibodies: A prediction method | Ren, J; Ellis, J; Li, J |
